Acurx Pharmaceuticals Newsroom

Maxim Group Maintains Acurx Pharmaceuticals(ACXP.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 15 01:31

Promising Prospects for Acurx Pharmaceuticals: Buy Rating Backed by Ibezapolstat's Efficacy and Strategic Positioning

TipRanksNov 15 00:50

HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

BenzingaNov 14 19:58

Maxim Group Maintains Acurx Pharmaceuticals(ACXP.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 2 20:32

Maxim Group Maintains Acurx Pharmaceuticals(ACXP.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 2 01:32

Buy Rating Affirmed for Acurx Pharmaceuticals Amid Positive Phase 2b Results and Strategic Pathway to Phase 3 Trials

TipRanksOct 2 01:18

Acurx Pharmaceuticals Analyst Ratings

BenzingaAug 12 19:01

HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

BenzingaAug 12 19:00

Ibezapolstat's Strategic Advancements and Market Potential Bolster Buy Rating for Acurx Pharmaceuticals

TipRanksAug 10 22:07

Maxim Group Sticks to Its Buy Rating for Acurx Pharmaceuticals (ACXP)

TipRanksMay 17 01:10

HC Wainwright & Co. : The Acurx Pharmaceuticals (ACXP.US) rating was reaffirmed, adjusted from buy to buy rating, and the target price was adjusted from $12.00 to $12.00.

Zhitong FinanceMay 16 18:51

Buy Rating Affirmed for Acurx Pharmaceuticals Amid Promising CDI Drug Candidate Progress and Solid Financials

TipRanksMay 16 18:45

Acurx Pharmaceuticals Analyst Ratings

BenzingaMay 16 18:45

HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

BenzingaMay 16 18:45

H.C. Wainwright Adjusts Price Target on Acurx Pharmaceuticals to $12 From $14, Keeps Buy Rating

MT NewswiresMar 19 21:34

Acurx Pharmaceuticals Analyst Ratings

BenzingaMar 19 18:35

HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Lowers Price Target to $12

BenzingaMar 19 18:35

HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $14 Price Target

BenzingaFeb 29 01:53

Buy Rating for Acurx Pharmaceuticals Amid Promising Phase 2 Results and Positive Regulatory Momentum

TipRanksFeb 28 19:39

Analysts' Top Healthcare Picks: Acurx Pharmaceuticals (ACXP), Champions Oncology (CSBR)

TipRanksJan 23 02:21